Media and News Releases
New NLR study predicts 90% leprosy reduction through preventive treatment of 40 million people in 22 years
2 March, 2021 | NLR International
To interrupt leprosy transmission and reduce annual new cases significantly, contact tracing and preventive treatment needs to be implemented in all leprosy-endemic countries Amsterdam, the Netherlands, March 1, 2021 – New research by NLR, until No Leprosy Remains (NLR) and Erasmus University … More New NLR study predicts 90% leprosy reduction through preventive treatment of 40 million people in 22 years
“Right to Work” Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy
29 January, 2021 | Sasakawa Leprosy Initiative
TOKYO/BRUSSELS, January 28, 2021 – The 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy will be launched in an online ceremony on January 31, 2021, World Leprosy Day. Organized by Sasakawa Leprosy (Hansen’s Disease) Initiative, this year’s … More “Right to Work” Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy
29 January, 2021 | Novartis
Basel, January 29, 2021 — A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the global push towards making leprosy history. The five-year extension of the partnership – which was first signed in 2000 – … More Novartis renews WHO medicine donation pledge with aim of ending leprosy
6 January, 2021 | ILEP Technical Commission
Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP), in light of recent information on nitrosamine impurities in rifampicin A number of different problems have affected the supply of rifampicin and MDT to countries this year. The most … More Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP)
9 December, 2020 | Alice Cruz
The Special Rapporteur on the elimination of discrimination against persons affected by Hansen’s disease and their family members, Alice Cruz, is preparing a report due to be presented at the 47th session of the Human Rights Council in June 2021. … More Call for Contributions from Persons Affected by Hansen’s Disease for Report to Human Rights Council
9 December, 2020 | World Health Organization
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021–2030. This virtual event took place from 26 to 30 October 2020. It was attended by more … More WHO Report on Global Leprosy Consultation 2020
12 November, 2020 | World Health Organization
12 November 2020 — Today, delegates attending the virtual session of the Seventy-third World Health Assembly overwhelmingly endorsed the new road map for neglected tropical diseases (NTDs) for 2021−2030. Ending the neglect to attain the Sustainable Development Goals: a road … More Neglected Tropical Diseases: World Health Assembly endorses bold new road map targets for 2030
Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19
4 November, 2020 | Sasakawa Health Foundation
TOKYO, Oct. 29, 2020 — Sasakawa Leprosy (Hansen’s Disease) Initiative will launch a US$340,000 grant program on November 1 to support communities of persons affected by leprosy around the world that have been hard hit by the effects of the … More Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19
Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
2 November, 2020 | Novartis International AG
Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is … More Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
Video: Conversation with Alice Cruz, UN Special Rapporteur on the Rights of Persons affected by Leprosy
11 June, 2019 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy talks with Alice Cruz, UN Special Rapporteur on the Rights of Persons affected by Leprosy, about the human rights challenges in leprosy work, and the role of the partnership in addressing these challenges.
24 May, 2019 | United Nations Human Rights Office of the High Commisioner
Statement by Ms. Alice Cruz, UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy, about her first official visit to Brazil as the United Nations Special Rapporteur, which took place between May 7th and May 14th.
22 April, 2019 | Global Partnership for Zero Leprosy
José Ramirez, Jr., Global Partnership for Zero Leprosy Board Member and IDEA President, talks about the role of people impacted by leprosy in leading the way to a leprosy-free world.
27 January, 2019 | Global Partnership for Zero Leprosy
In time for World Leprosy Day, Mathias Duck discusses how persons affected by leprosy can help empower others affected and improve interventions to reach Zero Leprosy.
25 January, 2019 | United Nations Human Rights Office of the High Commisioner
Media Statement by Ms. Alice Cruz, UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy Vea abajo la versión en español Pour la version en français, voir ci-dessous Para a versão em português, veja abaixo GENEVA (24 January … More Leprosy: We are failing our children
24 January, 2019 | Global Partnership for Zero Leprosy
In our new video, Mathias Duck speaks about the extreme forms of discrimination and stigma can take against persons affected by leprosy.
6 September, 2018 | World Health Organization
The modus operandi for leprosy control in all the WHO global strategies over the past 3 decades has been detection of all cases and prompt treatment with multidrug therapy (MDT). As the global target has been reached in all but a few countries, the most recent strategy indicates a shift from “elimination of leprosy as a public health problem” to reduction of the disease burden, measured as a reduction in grade-2 disabilities (G2D) among new cases and new cases in children.
20 August, 2018 | World Health Organization
WHO’s Global Leprosy Programme has released the full Guidelines for the diagnosis, treatment and prevention of leprosy. The Guidelines provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in low and middle-income countries. … More Guidelines for the diagnosis, treatment and prevention of leprosy
18 August, 2018 | Task Force for Global Health
Joseph Amon and David Addiss describe how drug doses alone can’t address neglected tropical disease (NTD)-related challenges such as mental health, stigma, and poverty. They argue that NTD programs should commit to caregiving for affected persons and adopt a human rights approach into the fight against NTDs.
17 August, 2018 | United Nations Human Rights Office of the High Commisioner
Politicians must stop misusing the word leprosy to convey harmful stereotypes because its widespread use as a metaphor for all that is loathsome contributes to violations of the human rights of persons affected by leprosy, says a UN expert. “Within … More Political leaders must stop misusing leprosy as a metaphor for harmful stereotypes, says UN expert